Immunic AG | WebDisclosure

BRÈVE

publiée le 26/02/2026 à 12:35, il y a 2 heures 59 minutes

Immunic, Inc. dévoile ses résultats financiers et ses plans stratégiques pour 2025

Sclérose En Plaques Vidofludimus Calcium Essais De Phase 3 Immunic Financials Investissement Privé
BRÈVE

publiée le 26/02/2026 à 12:35, il y a 2 heures 59 minutes

Immunic, Inc. Reveals 2025 Financial Outcomes and Strategic Plans

Multiple Sclerosis Vidofludimus Calcium Phase 3 Trials Immunic Financials Private Investment
COMMUNIQUÉ DE PRESSE

publié le 26/02/2026 à 12:30, il y a 3 heures 4 minutes

Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports year-end 2025 financial results, announces completion of private placement, and plans for MS programs advancement and commercial transition

Private Placement Immunic Inc. Multiple Sclerosis Year-end Results Commercial Transition
BRÈVE

publiée le 17/02/2026 à 22:10, il y a 8 jours 17 heures

Immunic obtient un financement important grâce à un placement privé sursouscrit.

Biotechnologie Placement Privé Participation Des Investisseurs Essais Cliniques Sur La Sclérose En Plaques Financement Immunitaire
BRÈVE

publiée le 17/02/2026 à 22:10, il y a 8 jours 17 heures

Immunic Secures Hefty Funding Through Oversubscribed Private Placement

Private Placement Biotechnology Multiple Sclerosis Trials Investor Participation Immunic Financing
COMMUNIQUÉ DE PRESSE

publié le 17/02/2026 à 22:05, il y a 8 jours 17 heures

Immunic Announces Closing of Oversubscribed Private Placement Financing
Immunic closes oversubscribed private placement financing of USD 200 million with potential for additional USD 200 million, aiming to fund phase 3 ENSURE trials and transition to commercialization

Private Placement Biotechnology Financing Immunic ENSURE Trials
BRÈVE

publiée le 13/02/2026 à 12:35, il y a 13 jours 2 heures

Immunic Secures USD 400 Million to Advance Commercial Ambitions

Private Placement Biotechnology Leadership Changes Multiple Sclerosis Immunic AG
BRÈVE

publiée le 13/02/2026 à 12:35, il y a 13 jours 2 heures

Immunic lève 400 millions de dollars pour accélérer ses ambitions commerciales

Biotechnologie Placement Privé Sclérose En Plaques Changements De Direction Immunic AG
COMMUNIQUÉ DE PRESSE

publié le 13/02/2026 à 12:30, il y a 13 jours 3 heures

Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company
Immunic announces oversubscribed private placement of up to USD 400 million to accelerate transformation into commercial-stage company. New leadership appointments to propel growth

Private Placement Growth Leadership Immunic Commercial-stage
BRÈVE

publiée le 04/02/2026 à 12:35, il y a 22 jours 2 heures

Immunic Unveils Promising Phase 2 Trial Results for Vidofludimus Calcium

Vidofludimus Calcium Phase 2 Trial Progressive Multiple Sclerosis ACTRIMS Forum 2026 Antiviral Effects

Publié le 26/02/2026 à 06:45, il y a 8 heures 49 minutes

AXA: FY25 earnings
Publié le 26/02/2026 à 06:45, il y a 8 heures 49 minutes

AXA: Résultats annuels 2025
Publié le 26/02/2026 à 01:17, il y a 14 heures 17 minutes

Liste des filiales et participations 2025
Publié le 26/02/2026 à 01:10, il y a 14 heures 24 minutes

Rapport d'activité et états financiers consolidés annuels 2025
Publié le 25/02/2026 à 20:06, il y a 19 heures 28 minutes

Evolution within ENGIE governance

Voir tout LES ECHOS COMFI WIRE

Publié le 26/02/2026 à 15:00, il y a 34 minutes

Golden Lake Announces Mailing of the Management Information Circular in Connection with its Annual General and Special Meeting of Securityholders to Approve the Acquisition by McEwen Inc.
Publié le 26/02/2026 à 15:00, il y a 34 minutes

Norsemont Invites Shareholders and Investment Community To Visit Us at Booth 3035 at PDAC 2026 in Toronto, March 1–4
Publié le 26/02/2026 à 15:00, il y a 34 minutes

Vox Royalty Acquires Producing Gold Royalty In New South Wales, Australia
Publié le 26/02/2026 à 14:30, il y a 1 heure 4 minutes

Loar Holdings Inc. Reports Q4 2025 and Full Year 2025 Record Results, and Upward Revisions to Full Year 2026 Outlook
Publié le 26/02/2026 à 14:30, il y a 1 heure 4 minutes

Solitario Receives Positive USFS Decision Memo Approving its Ponderosa Drilling Plan of Operations

Voir tout ACCESSWIRE

Publié le 26/02/2026 à 15:00, il y a 34 minutes

EQS-Adhoc: PAL Next AG Transitions Its Business Model to an Investment Strategy
Publié le 26/02/2026 à 14:50, il y a 44 minutes

Davenport Aviation Successfully Completes Virtus "First Shot," Validating Weaponized AS350/H125 Platform
Publié le 26/02/2026 à 14:30, il y a 1 heure 4 minutes

ADS-TEC Energy at Volta-Xchange: Flexibility is the key to solving today’s grid challenges
Publié le 26/02/2026 à 14:13, il y a 1 heure 21 minutes

Amundi Physical Metals plc: UK Final Terms
Publié le 26/02/2026 à 14:11, il y a 1 heure 23 minutes

2025 Annual Report and Accounts

Voir tout EQS

News